Analytical Data
-
Gene name
FOXI1
- Application
-
Alternative Names
FOX-I1; FKHL10; FREAC6; Forkhead-related transcription factor 6; Forkhead-related protein FKHL10; Hepatocyte nuclear factor 3 forkhead homolog 3
-
Species
Mouse
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q922I5
-
Expression Region
Met1~Asp173
-
Molecular Weight
25kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FOXI1, a member of the forkhead box (Fox) transcription factor family, plays a crucial role in various biological processes, particularly in the development and function of epithelial tissues, including the thyroid gland and the respiratory system. The importance of FOXI1 in regulating gene expression related to ion transport, epithelial structure, and cell differentiation has made it a significant focus of research in both developmental biology and disease pathology. Abnormalities in FOXI1 expression have been implicated in several disorders, such as thyroid dysgenesis and congenital hearing loss, highlighting its potential as a biomarker or therapeutic target. The investigation of FOXI1 recombinant protein is essential for elucidating its functional mechanisms and interactions with other cellular factors. By producing and characterizing FOXI1 in a recombinant format, researchers aim to better understand its structural properties, binding affinities, and biological activities. This knowledge is pivotal for developing targeted interventions in diseases associated with FOXI1 dysregulation and advancing our understanding of transcriptional control in epithelial biology. Overall, the study of FOXI1 recombinant proteins promises to provide insights into both fundamental biological processes and potential clinical applications in regenerative medicine and molecular therapies.
